Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1974 Jan;74(1):179–210.

Hepatoma--nature's model tumor. A review.

F F Becker
PMCID: PMC1910723  PMID: 4358463

Full text

PDF
178-1

Images in this article

205Fig 10
on p.205
205Fig 11
on p.205
206Fig 12
on p.206
206Fig 13
on p.206
207Fig 14
on p.207
207Fig 15
on p.207
208Fig 16
on p.208
208Fig 17
on p.208
209Fig 18
on p.209
209Fig 19
on p.209
201Fig 1
on p.201
201Fig 2
on p.201
201Fig 3
on p.201
210Fig 20
on p.210
210Fig 21
on p.210
202Fig 4
on p.202
202Fig 5
on p.202
203Figs 6 and 7
on p.203
204Fig 8
on p.204
204Fig 9
on p.204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelev G. I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res. 1971;14:295–358. doi: 10.1016/s0065-230x(08)60523-0. [DOI] [PubMed] [Google Scholar]
  2. Alpert M. E., Davidson C. S. Mycotoxins. A possible cause of primary carcinoma of the liver. Am J Med. 1969 Mar;46(3):325–329. doi: 10.1016/0002-9343(69)90035-7. [DOI] [PubMed] [Google Scholar]
  3. Alpert M. E., Hutt M. S., Davidson C. S. Primary hepatoma in Uganda. A prospective clinical and epidemiologic study of forty-six patients. Am J Med. 1969 May;46(5):794–802. doi: 10.1016/0002-9343(69)90030-8. [DOI] [PubMed] [Google Scholar]
  4. Alpert M. E., Hutt M. S., Wogan G. N., Davidson C. S. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer. 1971 Jul;28(1):253–260. doi: 10.1002/1097-0142(197107)28:1<253::aid-cncr2820280151>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. Ariel I. M., Pack G. T. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer. 1967 May;20(5):793–804. doi: 10.1002/1097-0142(1967)20:5<793::aid-cncr2820200534>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. BOTTOMLEY R. H., PITOT H. C., MORRIS H. P. Metabolic adaptations in rat hepatomas. IV. Regulation of threonine and serine dehydrase. Cancer Res. 1963 Mar;23:392–399. [PubMed] [Google Scholar]
  7. Becker F. F., Fox R. A., Klein K. M., Wolman S. R. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis. J Natl Cancer Inst. 1971 Jun;46(6):1261–1269. [PubMed] [Google Scholar]
  8. Becker F. F., Klein K. M. The effect of L-asparaginase on mitotic activity during N-2-fluorenylacetamide hepatocarcinogenesis: subpopulations of nodular cells. Cancer Res. 1971 Feb;31(2):169–173. [PubMed] [Google Scholar]
  9. Becker F. F., Klein K. M. The synergistic effect of hypoglycemia and L-asparaginase upon transplantable hepatomas of varying growth rates. Cancer Res. 1972 Oct;32(10):2082–2084. [PubMed] [Google Scholar]
  10. Blank R. J., Tysan I. B. Intra-arterial 131-I-macroaggregated albumin to define intrahepatic tumors: a possible method of quantitating tumor response to therapy. J Nucl Med. 1969 Jul;10(7):514–516. [PubMed] [Google Scholar]
  11. Brasfield R. D., Bowden L., McPeak C. J. Major hepatic resection for malignant neoplasms of the liver. Ann Surg. 1972 Aug;176(2):171–177. doi: 10.1097/00000658-197208000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brownstein M. H., Ballard H. S. Hepatoma associated with erythrocytosis. Am J Med. 1966 Feb;40(2):204–210. doi: 10.1016/0002-9343(66)90101-x. [DOI] [PubMed] [Google Scholar]
  13. Bucher N. L. Experimental aspects of hepatic regeneration. N Engl J Med. 1967 Oct 5;277(14):738–concl. doi: 10.1056/NEJM196710052771405. [DOI] [PubMed] [Google Scholar]
  14. Christiansen R. O., Page L. A., Greenberg R. E. Glycogen storage in a hepatoma: dephosphophosphorylase kinase defect. Pediatrics. 1968 Oct;42(4):694–696. [PubMed] [Google Scholar]
  15. Colwell J. A., Wilber J. F. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep;20(9):607–614. doi: 10.2337/diab.20.9.607. [DOI] [PubMed] [Google Scholar]
  16. Daoust R. Focal loss of ribonuclease activity in preneoplastic rat liver. Cancer Res. 1972 Nov;32(11):2502–2509. [PubMed] [Google Scholar]
  17. Dillard B. M. Experience with twenty-six hepatic lobectomies and extensive hepatic resections. Surg Gynecol Obstet. 1969 Aug;129(2):249–257. [PubMed] [Google Scholar]
  18. Epstein S., Ito N., Merkow L., Farber E. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism. Cancer Res. 1967 Sep;27(9):1702–1711. [PubMed] [Google Scholar]
  19. Filler R. M., Tefft M., Vawter F., Maddock C., Mitus A. Hepatic lobectomy in childhood: effectws of x-ray and chemotherapy. J Pediatr Surg. 1969 Feb;4(1):31–41. doi: 10.1016/0022-3468(69)90181-x. [DOI] [PubMed] [Google Scholar]
  20. GALL E. A. Posthepatitic, postnecrotic, and nutritional cirrhosis: a pathologic analysis. Am J Pathol. 1960 Mar;36:241–271. [PMC free article] [PubMed] [Google Scholar]
  21. Gordon A. S., Zanjani E. D., Zalusky R. A possible mechanism for the erythrocytosis associated with hepatocellular carcinoma in man. Blood. 1970 Feb;35(2):151–157. [PubMed] [Google Scholar]
  22. HESTON W. E., VLAHAKIS G., DERINGER M. K. High incidence of spontaneous hepatomas and the increase of this incidence with urethan in C3H, C3Hf, and C3He male mice. J Natl Cancer Inst. 1960 Feb;24:425–435. [PubMed] [Google Scholar]
  23. Harris P. N., Chen K. K. Development of hepatic tumors in rats following ingestion of Senecio longilobus. Cancer Res. 1970 Dec;30(12):2881–2886. [PubMed] [Google Scholar]
  24. Higginson J., Svoboda D. J. Primary carcinoma of the liver as a pathologist's problem. Pathol Annu. 1970;5:61–89. [PubMed] [Google Scholar]
  25. KAMPSCHMIDT R. F. MECHANISM OF LIVER CATALASE DEPRESSION IN TUMOR-BEARING ANIMALS: A REVIEW. Cancer Res. 1965 Jan;25:34–45. [PubMed] [Google Scholar]
  26. Knill-Jones R. P., Buckle R. M., Parsons V., Calne R. Y., Williams R. Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med. 1970 Mar 26;282(13):704–708. doi: 10.1056/NEJM197003262821302. [DOI] [PubMed] [Google Scholar]
  27. Kreisberg R. A., Pennington L. F. Tumor hypoglycemia: a heterogeneous disorder. Metabolism. 1970 Jun;19(6):445–452. doi: 10.1016/0026-0495(70)90096-x. [DOI] [PubMed] [Google Scholar]
  28. Kroes R., Williams G. M., Weisburger J. H. Early appearance of serum -fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1972 Jul;32(7):1526–1532. [PubMed] [Google Scholar]
  29. LAQUEUR G. L. CARCINOGENIC EFFECTS OF CYCAD MEAL AND CYCASIN, METHYLAZOXYMETHANOL GLYCOSIDE, IN RATS AND EFFECTS OF CYCASIN IN GERMFREE RATS. Fed Proc. 1964 Nov-Dec;23:1386–1388. [PubMed] [Google Scholar]
  30. Lee F. I. Cirrhosis and hepatoma in alcoholics. Gut. 1966 Feb;7(1):77–85. doi: 10.1136/gut.7.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. MACDONALD R. A. Primary carcinoma of the liver; a clinicopathologic study of one hundred eight cases. AMA Arch Intern Med. 1957 Feb;99(2):266–279. doi: 10.1001/archinte.1957.00260020102015. [DOI] [PubMed] [Google Scholar]
  32. McFadzean A. J., Yeung R. T. Further observations on hypoglycaemia in hepatocellular carcinoma. Am J Med. 1969 Aug;47(2):220–235. doi: 10.1016/0002-9343(69)90148-x. [DOI] [PubMed] [Google Scholar]
  33. Miller J. A. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res. 1970 Mar;30(3):559–576. [PubMed] [Google Scholar]
  34. Miura T., Sugimura M., Ishida M., Endo Y., Oda T. [Intra-arterial chemotherapy of primary hepatoma and changes in -fetoprotein levels]. Nihon Rinsho. 1972 May;30(5):1201–1208. [PubMed] [Google Scholar]
  35. Moertel C. G., Gleich G. J., Hull E. W. Australia antigen and primary liver cancer. Am J Dig Dis. 1970 Nov;15(11):983–985. doi: 10.1007/BF02232815. [DOI] [PubMed] [Google Scholar]
  36. Morgan A. G., Walker W. C., Mason M. K., Herlinger H., Losowsky M. S. A new syndrome associated with hepatocellular carcinoma. Gastroenterology. 1972 Aug;63(2):340–345. [PubMed] [Google Scholar]
  37. Mori W. Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati. Cancer. 1967 May;20(5):627–631. doi: 10.1002/1097-0142(1967)20:5<627::aid-cncr2820200509>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  38. Nakao K., Kimura K., Miura Y., Takaku F. Erythrocytosis associated with carcinoma of the liver (with erythropoietin assay of tumor extract). Am J Med Sci. 1966 Feb;251(2):161–165. doi: 10.1097/00000441-196602000-00006. [DOI] [PubMed] [Google Scholar]
  39. Nayak N. C., Chawla V., Malaviya A. N., Chandra R. K. -fetoprotein in indian childhood cirrhosis. Lancet. 1972 Jan 8;1(7741):68–69. doi: 10.1016/s0140-6736(72)90064-5. [DOI] [PubMed] [Google Scholar]
  40. Nebesar R. A., Pollard J. J., Stone D. L. Angiographic diagnosis of malignant disease of the liver. Radiology. 1966 Feb;86(2):284–292. doi: 10.1148/86.2.284. [DOI] [PubMed] [Google Scholar]
  41. Nishioka M., Hironaga K., Fujita T. Polyacrylamide gel electrophoresis of sera from patients with primary liver carcinoma. Clin Chim Acta. 1971 Feb;31(2):439–446. doi: 10.1016/0009-8981(71)90416-5. [DOI] [PubMed] [Google Scholar]
  42. Nishioka M., Ibata T., Okita K., Harada T., Fujita T. Localization of -fetoprotein in hepatoma tissues by immunofluorescence. Cancer Res. 1972 Jan;32(1):162–166. [PubMed] [Google Scholar]
  43. OETTLE A. G. CANCER IN AFRICA, ESPECIALLY IN REGIONS SOUTH OF THE SAHARA. J Natl Cancer Inst. 1964 Sep;33:383–439. [PubMed] [Google Scholar]
  44. Onuigbo W. I. Cancer permeation: processes, problems, and prospects--a review. Cancer Res. 1973 Apr;33(4):633–636. [PubMed] [Google Scholar]
  45. Parker J. C., Jr, Dahlin D. C., Stauffer M. H. Malignant hepatoma: evaluation of surgical (including needle biopsy) material from 69 cases. Mayo Clin Proc. 1970 Jan;45(1):25–35. [PubMed] [Google Scholar]
  46. Pitot H. C. Recent advances in the mechanism of hepatic carcinogenesis. Prog Liver Dis. 1970;3:77–88. [PubMed] [Google Scholar]
  47. Primack A., Wilson J., O'Connor G. T., Engelman K., Hull E., Canellos G. P. Hepatocellular carcinoma with the carcinoid syndrome. Cancer. 1971 May;27(5):1182–1189. doi: 10.1002/1097-0142(197105)27:5<1182::aid-cncr2820270525>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  48. Purves L. R., Bersohn I., Geddes E. W. Serum alpha-feto-protein and primary cancer of the liver in man. Cancer. 1970 Jun;25(6):1261–1270. doi: 10.1002/1097-0142(197006)25:6<1261::aid-cncr2820250603>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  49. QUATTLEBAUM J. K. Massive resection of the liver. Ann Surg. 1953 Jun;137(6):787–796. doi: 10.1097/00000658-195306000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. SAGEBIEL R. W., MCFARLAND R. B., TAFT E. B. PRIMARY CARCINOMA OF THE LIVER IN RELATION TO CIRRHOSIS. Am J Clin Pathol. 1963 Nov;40:516–520. doi: 10.1093/ajcp/40.5.516. [DOI] [PubMed] [Google Scholar]
  51. Smetana K., Gyorkey F., Gyorkey P., Busch H. Studies on nucleoli and cytoplasmic fibrillar bodies of human hepatocellular carcinomas. Cancer Res. 1972 May;32(5):925–932. [PubMed] [Google Scholar]
  52. Smith J. A., Francis T. I. Immunoepidemiological and in vitro studies of possible relationships between Australia antigen and hepatocellular carcinoma. Cancer Res. 1972 Aug;32(8):1713–1720. [PubMed] [Google Scholar]
  53. Stanislawski-Birencwajg M., Uriel J., Grabar P. Association of embryonic antigens with experimentally induced hepatic lesions in the rat. Cancer Res. 1967 Nov;27(11):1990–1997. [PubMed] [Google Scholar]
  54. Sutnick A. I., London W. T., Blumberg B. S. Australia antigen: a genetic basis for chronic liver disease and hepatoma? Ann Intern Med. 1971 Mar;74(3):443–444. [PubMed] [Google Scholar]
  55. TATARINOV Iu S. OBNARUZHENIE EMBRIOSPETSIFICHESKOGO ALPHA-GLOBULINA V SYVOROTKE KROVI BOL'NOGO PERVICHNYM RAKOM PECHENI. Vopr Med Khim. 1964 Jan-Feb;10:90–91. [PubMed] [Google Scholar]
  56. THOMPSON W. T., Jr, HIGGINS W. H., Jr Primary carcinoma of the liver. Va Med Mon (1918) 1952 Jun;79(6):305–309. [PubMed] [Google Scholar]
  57. Teebor G. W., Becker F. F. Regression and persistence of hyperplastic hepatic nodules induced by N-2-Fluorenylacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 1971 Jan;31(1):1–3. [PubMed] [Google Scholar]
  58. Tong M. J., Sun S. C., Schaeffer B. T., Chang N. K., Lo K. J., Peters R. L. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 1971 Nov;75(5):687–691. doi: 10.7326/0003-4819-75-5-687. [DOI] [PubMed] [Google Scholar]
  59. Weinhouse S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res. 1972 Oct;32(10):2007–2016. [PubMed] [Google Scholar]
  60. Wills E. J. Fine structure and surface adenosinetriphosphatase activity of a human hepatoma. Cancer. 1968 Nov;22(5):1046–1052. doi: 10.1002/1097-0142(196811)22:5<1046::aid-cncr2820220521>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  61. Wogan G. N., Newberne P. M. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res. 1967 Dec;27(12):2370–2376. [PubMed] [Google Scholar]
  62. Wolff G. L. Differential growth of hepatoma-susceptible liver induced by gene X genome interaction. Cancer Res. 1970 Jun;30(6):1722–1725. [PubMed] [Google Scholar]
  63. von Felten A., Straub P. W., Frick P. G. Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation. N Engl J Med. 1969 Feb 20;280(8):405–409. doi: 10.1056/NEJM196902202800802. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES